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ABSTRACT
Objectives: To determine the utility of  liver biopsy in providing a diagnosis in HIV-
infected patients presenting with  febrile illnesses and inconclusive initial investigative 
work up.
Design: A retrospective descriptive study.
Setting: The Aga Khan University Hospital, Nairobi.
Subjects: Twelve in-patients with HIV disease who underwent  liver biopsy following 
inconclusive initial investigative work up for febrile illnesses between January and 
December 2007.
Results: Seven out of 12 patients had granulomatous hepatitis reported on histology 
with characteristic tuberculous epitheloid granulomas all having stainable acid-alcohol 
fast bacilli on Ziehl-Nielsen (ZN) stain. The mean alkaline phosphatase (ALP) and 
gamma glutamyl transpeptidase (GGT) levels in these seven patients were 260U/L and 
304U/L respectively, while the mean aspartate aminotransferase   (SGOT) and alanine 
aminotransferase (SGPT) were 106U/L and 72U/L respectively.
Conclusion: Disseminated tuberculosis is still among the most common causes of 
unexplained pyrexia in our HIV- infected cohort and a liver biopsy, performed earlier 
in the investigative work up of unexplained fever in the HIV-infected patient, would 
be a useful adjunct in providing a diagnosis.
INTRODUCTION
Physicians taking care of patients with Human 
Immunodeﬁciency Virus (HIV) infection routinely 
come across patients presenting with febrile illnesses 
and are posed not only with the challenge of making an 
appropriate diagnosis but initiating evidence-based 
therapy especially when the initial ‘septic-screen’ is 
reported normal.
 With differential diagnosis ranging from 
infections to malignancies to less common connective 
tissue disorders among others, most patients undergo 
ﬁrst line investigations including a full blood count, 
malaria slides, sputum microscopy and culture, 
urinalysis, chest radiographs and blood cultures 
since the commoner cause of a febrile illness in HIV 
infected patients in our settings is infective. If these 
non-invasive investigations are non conclusive, 
patients are then subjected to lymph node biopsies 
(if present and accessible), bone marrow aspirate 
(BMA) and cultures and a liver biopsy.
 In clinical practice, due to the endemicity of 
tuberculosis in the HIV infected population, the 
atypically bland manner of its presentation, and the 
signiﬁcant morbidity, mortality and public health 
concern associated with untreated tuberculosis, most 
patients would be initiated on an empirical ‘trial of 
anti- tuberculous therapy’ if the initial septic screen 
is reported normal.
 Autopsy studies done in Kenya on HIV   infected 
adults found previously undiagnosed tuberculosis 
present in 50% of the cases, 80% of whom had 
disseminated disease. In over half of the patients who 
had disseminated disease, tuberculous granulomas 
were evident in the liver (1). 
 We therefore decided to evaluate the role of a 
liver biopsy in HIV infected patients presenting with 
a febrile illness and having an inconclusive diagnostic 
work up.
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MATERIALS AND METHODS 
A retrospective study performed between January and 
December 2007 at The Aga Khan University Hospital, 
Nairobi, where twelve HIV infected patients who 
presented with a febrile illness for a mean duration 
of 2.1 weeks, underwent the following investigations 
as part of the initial septic screen:
(i) Full blood count and malaria slides.
(ii) Sputum (induced with 3% saline, if cough was 
non productive) for microscopy and a Ziehl 
Nielsen stain. 
(iii) Urine and blood cultures obtained prior to 
initiation of empirical antibiotics.
(iv) Chest radiograph. 
Patients, who had inconclusive initial septic screen, 
underwent a repeat physical examination looking 
particularly for evidence of lymphadenopathy. 
Patients who did not have enlarged lymph nodes 
or declined consent for excision underwent a bone 
marrow aspirate (BMA) followed by a diagnostic liver 
biopsy if the BMA cytology was inconclusive.
Baseline characteristics: The median age of the cohort 
was 40 years (range 32-47years) and sex ratio 
distributed as M:F = 1:2. The baseline characteristics of 
all twelve patients are shown in  Table 1. The pertinent 
liver function tests are illustrated in Table 2.
Table 1
Baseline characteristics
Age  Sex  WBC LYM ESR CXR URINE C/S BLOOD C/S CD4
41 M 6.5 6% 50 N NG NG 42
40 F 6.4 13% 72 N NG NG NA
43 M 6.7 22% 43 NON SP INF NG NG 215
33 F 5.9 43% 38 N NG NA NA
43 M 2.9 41% 47 N NG NG 28
40 F 2.2 31% 15 N NG NG 13
39 F 4.2 54% 36 N NG NG NA
47 M 5.9 9% 30 N NG NG 490
35 F 7.2 4% 70 N NG NG 50
30 F 5.7 10% 64 N NG NG 13
32 F 1.6 9% 68 N NG NG 314
42 F 6.3 20% 65 N NG NG 73
Age  = Expressed in years URINE C/S =  Urine culture and sensitivity
Sex  = M – male F – female  BLOOD C/S =  Blood culture and sensitivity 
WBC = White cell count CD4  =  CD4 count (cells/mm3)      
LYM = Lymphocyte ESR  =  Erythrocyte sedimentation rate
CXR = Chest X-ray NON SP INF =  Non speciﬁc infective process
NA = Not available NG =  No growth
Table 2
Liver function tests
ALP GGT SGOT SGPT
99 124 107 58
202 131 63 47
238 696 121 108
814 371 56 64
182 148 40 40
192 471 63 41
52 29 33 10
68 351 93 53
221 345 307 226
216 417 80 62
98 86 40 18
151 352 45 70
ALP = Alkaline phosphatase (U/L)   GGT  = Gamma glutamyl transpeptidase (U/L)
SGOT = Aspartate aminotransferase (U/L)  SGPT = Alanine aminotransferase (U/L)
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RESULTS
Majority of the patients in the study (83%) had an 
absolute lymphopenia (<1.5x109/L) with a mean 
lymphocyte count of 1.01 x 109/L (0.14 – 2.54 x 109/L). 
This was reﬂected in the mean CD4 count of 137cells/
mm3 (13 – 490 cell/mm3). The mean ESR for our study 
patients was 50mm/hour (15 – 72mm/hour). 
 All patients, who had blood and urine cultures 
drawn prior to initiation of empirical antibiotic 
therapy, had no growth at 48 hours. All chest 
radiographs were reported as normal, except one 
who had a non speciﬁc infective pneumonitis. The 
mean alkaline phopshatase (ALP) and gamma 
glutamyl transpeptidase (GGT) of the cohort was 
211U/L and 293U/L respectively. Liver transaminases 
were elevated in 75% of the patients with the mean 
aspartate aminotransferase (SGOT) at 67U/L and 
alanine aminotransferase (SGPT) at 64U/L. 
 All but one patient had either no evidence or 
non- accessible lymphadenopathy. The one patient 
had anterior cervical lymphadenopathy but declined 
consent for an excisional lymph node biopsy. On 
evaluation of the bone marrow aspirates, no patient 
had cytological evidence of lymphoma. One patient 
had M. tuberculosis while another had mycobacteria 
other than tuberculosis (MOTT) grown on bone 
marrow culture at ﬁve weeks.
 All twelve patients underwent a liver biopsy 
since the BMA was inconclusive while bone marrow 
culture reports were awaited. Seven out of the 12 
biopsies showed features of tuberculous hepatitis 
with preservation of the liver architecture. Five of 
the seven showed well deﬁned classical necrotising 
granulomas with epithelioid cells and the remaining 
two showed ill deﬁned non epithelioid focal areas of 
necrosis with neutrophilic inﬁltrate predominantly. 
All seven biopsies had acid alcohol fast bacilli on 
ZN staining, ﬁve on the initial sections and two on 
deeper sections.
 Of the ﬁve cases that did not show tuberculous 
hepatitis, two showed steatohepatitis (one having 
cirrhosis), while the rest showed chronic hepatitis of 
mild activity and no ﬁbrosis on the Ishaak scoring 
system (1).      
 On sub-analysis of the seven patients who had 
granulomas on liver biopsy, the mean ALP and GGT 
levels were 260U/L and 304U/L respectively, while 
the mean SGOT and SGPT were 106U/L and 72U/L 
respectively.
 Ten patients were both hepatitis B surface 
antigen (HBsAg) and hepatitis C antibody (anti 
HCV antibody) negative. The HBsAg and anti HCV 
antibody results of the remaining two patients 
were not available. However, all patients who had 
granulomatous hepatitis were HBsAg and anti HCV 
negative.
DISCUSSION
Fever of unknown or uncertain origin (FUO) 
constitutes a common clinical challenge in patients 
infected with HIV. It becomes more frustrating after 
the initial investigations fail to identify the source of 
their fever, as this not only increases patient hospital 
stay but also puts them through more invasive 
investigative work-up. Our study results were similar 
to results from Rana et al (2) who reported from the 
same geographical setting, and in close approximation 
to results from Nigeria where 65% of HIV infected 
patients who underwent a post-mortem liver biopsy 
had evidence of tuberculosis (3).
 García-Ordóñez et al (4) found tuberculosis in 
50% of their percutaneous liver biopsies from HIV-
infected patients presenting with FUO. They also 
reported leishmaniasis in 20% of their cohort. Despite 
the existence of leishmaniasis endemic areas and 
publications of leishmania outbreaks in Kenya (5-7), 
we interestingly did not ﬁnd any case of leishmaniasis 
in our HIV-infected cohort.
 Other studies in developing countries have 
however reported a much lower prevalence of 
tuberculous hepatitis in HIV infected patients. 
Amarapurkar et al (8) demonstrated a prevelance 
rate of about 36% while Piratvisuth et al (9) had a 
prevalence rate of 33%.
 From our study cohort, patients who had 
tuberculous hepatitis on biopsy had a two-fold 
increase in their mean liver transaminase levels, 
and a several fold increase in their ALP and GGT 
levels. The results of this study, although limited by 
its small numbers, demonstrate that a liver biopsy 
would increase the diagnostic yield for mycobacterial 
infections in patients with HIV/AIDS presenting with 
a febrile illness and a non diagnostic initial work 
up. This is especially so in patients who also have 
derangements in their liver function tests. All patients 
who had granulomatous hepatitis were treated for M. 
tuberculosis, except one patient whose bone marrow 
culture was positive for MOTT.
 We therefore recommend that a liver biopsy 
be performed earlier in the diagnostic hierarchy of 
unexplained fever in HIV – infected patients, since it 
leads to a change in the clinical management of such 
patients.
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